Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The need for kidney biopsy in suspected primary membranous nephropathy with typical clinical presentation and positive anti-PLA2R antibodies.

Medicina clinica·2026
Same author

Association of Anuria and Ultrafiltration Rate with Mortality in Chronic Hemodialysis: A 10-Year Cohort Study.

Blood purification·2026
Same author

[Bone metaplasia in lupus nephritis].

Medicina·2025
Same author

Dusseux score: A simple clinical tool to predict post-transplant mortality in elderly kidney recipients.

Nefrologia·2025
Same author

[Daily sodium intake determined in 24-hour urine in healthy adults and adults with comorbidities in Argentina].

Medicina·2025
Same author

Long-term outcomes of ABO-incompatible kidney transplantation in Argentina: A 10-years single-center experience.

Transplant immunology·2025

相关实验视频

Updated: Jul 7, 2026

Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging
08:31

Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging

Published on: January 27, 2015

利图西马布用于异常病变的膜性脏病.

Giuseppe Remuzzi1, Carlos Chiurchiu, Mauro Abbate

  • 1Ospedali Riuniti Di Bergam, Unit of Nephrology and Dialysis, Aldo and Cele Daccò Clinical Research Centre for Diseases, Mario Negri Institute for Parmacological Research, Via Gavazzeni 1124125, Bergamo, Italy. gremuzzi@marionegri.it

Lancet (London, England)
|October 2, 2002
PubMed
概括
此摘要是机器生成的。

作为B细胞疗法之一的Rituximab在患有异常性膜性腎病症的患者中显著降低了蛋白尿. 与其他免疫抑制剂相比,这种治疗显示出有利的短期风险益处概况.

更多相关视频

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases
13:18

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases

Published on: September 20, 2016

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

相关实验视频

Last Updated: Jul 7, 2026

Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging
08:31

Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging

Published on: January 27, 2015

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases
13:18

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases

Published on: September 20, 2016

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學.
  • 免疫学 免疫学 免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 异形膜性病 (IMN) 是综合征的主要原因.
  • 目前用于IMN的治疗方法具有显著的毒性风险.
  • B细胞在IMN的发病过程中起着至关重要的作用.

研究的目的:

  • 评估利图西马布在治疗持久性异常病变性膜性脏病的疗效和安全性.
  • 评估利图西马布对蛋白尿,白蛋白尿和血清白蛋白水平的影响.

主要方法:

  • 八名IMN和持久性性综合征的患者每周接受四次Rituximab (375 mg/m2) 输注.
  • 利图西马布向CD20B细胞抗原.
  • 临床和实验室参数被监测到研究结束.

主要成果:

  • 尿蛋白显著减少,从8.6g/24h到3.8g/24h在第4周和3.7g/24h在第20周 (p<0.0001).
  • 在第20周,白蛋白尿和白蛋白分片清除率分别下降了70%和65%.
  • 血清白蛋白在第20周增加了31%.
  • 在整个研究过程中,CD20 B淋巴细胞下降到正常范围以下.

结论:

  • 利图西马布在治疗IMN时表现出有利的短期风险效益概况.
  • 用Rituximab消耗B细胞是一种有效的治疗策略,用于异常性膜性病.
  • 需要进一步的研究来确认长期的疗效和安全性.